ISRO tour inspires Jharkhand girls
PTI
Last Updated:
Jamshedpur, Aug 14 (PTI) A group of 28 girl students from government-run schools in Jharkhand's East Singhbhum district on Thursday shared their experiences following their return from a three-day academic trip to ISRO's Satish Dhawan Space Centre in Sriharikota.
Speaking at a function organised at the district collectorate here on Thursday, the students said the tour had broadened their knowledge, vision and aspirations.
They thanked Chief Minister Hemant Soren and East Singhbhum Deputy Commissioner Karn Satyarthi for organising the academic trip.
On the first day, the students visited the Indian Space Research Organisation's Satish Dhawan Space Centre in Shriharikota (Andhra Pradesh) and the engineering college of RMK Group of Institutions.
On the second day, they visited the state museum and various Archaeological Survey of India-protected historical sites, including the Mahabalipuram Fort, temples, museums, and Tiger Cave.
They also paid a visit to a model school in Kovalam, Chennai, to observe the current educational system and resources.
On the final day, the group toured the MA Chidambaram Stadium in Chennai and the railway museum in the city, where they learned about the history and development of Indian Railways.
Selected through the Science Olympiad, the tour was proved a unique experience for students, who witnessed a co-ordination of science, culture and education.
Deputy Commissioner Satyarthi said such tours provide an opportunity for students to move out from the confines of classrooms and understand the real world, broadening their thinking and vision.
'Such tours would not only encourage keenness to learn, but also boost their confidence, curiosity to achieve goal with commitment," he added.
Satyarthi expressed confidence that these girls, inspired by the experience, will put up their best and earn laurels for the state and country in science and technology, research and sports. PTI BS MNB
view comments
First Published:
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
3 hours ago
- Mint
Lok Sabha to discuss astronaut Shubhanshu Shukla's return to India tomorrow
The Lok Sabha will hold a special discussion on Monday on the subject 'India's first astronaut aboard the International Space Station – Critical role of the space programme for Viksit Bharat by 2047 – to mark Astronaut Shubhanshu Shukla's return to India. Shukla returned to India early Sunday to a rousing welcome by a large number of people waving the tricolour and beating drums at the airport here to celebrate his historic visit to the International Space Station (ISS). The Monsoon Session of Parliament will resume on Monday, 18 August after a brief break, but there are no signs of a thaw between the government and the Opposition over the demand for a debate on Special Intensive Revision (SIR) of electoral rolls. The Monsoon Session ends on 21 August. Shukla is expected to meet Prime Minister Narendra Modi on Monday and travel to his hometown, Lucknow. He is also expected to return to the capital to participate in the National Space Day celebrations on August 22-23. Shukla, who became the second Indian to undertake a spaceflight as part of the Axiom-4 mission, and his back-up astronaut-designate Prashanth Balakrishnan Nair were welcomed at the airport by Union Minister Jitendra Singh, Delhi Chief Minister Rekha Gupta, and ISRO Chairman V Narayanan. "Thank you sir. Surely feels good to be back home," Shukla posted on X in response to Singh's post welcoming after receiving him at the airport. Shukla's wife Kamna and son Kiash were also present at the airport to welcome him home after a nearly one-year stay in the US training for the space flight, which finally took place from June 25 to July 15. A large crowd waving the national tri-colour had gathered at the Indira Gandhi International Airport here to welcome Shukla to the sound of drumbeats. "India's space glory touches Indian soil... as the iconic son of Mother India, Gaganyatri Shubhanshu Shukla, lands in Delhi in the early hours of this morning. Accompanying him, another equally accomplished Group Captain Prashanth Balakrishnan Nair, one of the astronauts selected for India's first human mission Gaganyaan, who was India's designated backup for the mission to the International Space Station #ISS," Singh said in a post on X. Shukla was part of the Axiom-4 private space mission that lifted off from Florida on June 25 and docked at the International Space Station on June 26. He returned to Earth on 15 July. Along with three other astronauts - Peggy Whitson (US), Slawosz Uznanski-Wisniewski (Poland), and Tibor Kapu (Hungary) - Shukla conducted over 60 experiments and 20 outreach sessions during the 18-day mission Earlier on Saturday, Shukla had posted a smiling photograph of himself sitting in an aeroplane on Instagram, saying he was filled with mixed emotions as he left the US and looked forward to returning to India to share his experiences with everyone back home. Shukla and his backup astronaut Nair participated in the Independence Day celebrations at the Indian Consulate in Houston on Friday. Addressing the 79th Independence Day celebrations at the Red Fort, Prime Minister Modi on Friday said India was developing its own space station and noted that Group Captain Shukla had returned from a space mission. "Our Group Captain Shubhanshu Shukla has returned from the space station. In the coming days, he is returning to India," Modi had said.
Economic Times
3 hours ago
- Economic Times
Lok Sabha to hold special discussion on astronaut Shubhanshu Shukla tomorrow
Shubhanshu Shukla, India's first astronaut on the ISS, has returned home. He was welcomed by Union Minister Jitendra Singh and others. A special discussion on India's space program is scheduled in Lok Sabha. Shukla will meet Prime Minister Narendra Modi and participate in National Space Day. He shared his experiences and excitement about returning to India. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads The Lok Sabha is set to hold a discussion on special discussion on India's first astronaut aboard the International Space Station - critical role of space programme for 'Viksit Bharat by 2047' on Monday following Shubhanshu Shukla 's return to India after a successful stint at the ISS on who was the part of the Axiom-4 mission to the ISS, was welcomed at the airport by Union Minister Jitendra Singh, Delhi Chief Minister Rekha Gupta, and ISRO Chairman V Narayanan. His backup astronaut, Prashanth Balakrishnan Nair, also returned to the is expected to meet Prime Minister Narendra Modi and travel to his hometown, Lucknow . He is also expected to return to the national capital to participate in the National Space Day celebrations on August on Saturday, Shukla had posted a smiling photograph of himself sitting in an airplane on Instagram, saying he was filled with mixed emotions as he left the US and looked forward to returning to India to share his experiences with everyone back home."As I sit on the plane to come back to India, I have a mix of emotions running through my heart. I feel sad leaving a fantastic group of people behind who were my friends and family for the past year during this mission. I am also excited about meeting all my friends, family, and everyone in the country for the first time post-mission. I guess this is what life is - everything all at once," Shukla said in the post."Having received incredible love and support from everyone during and after the mission, I can't wait to come back to India to share my experiences with all of you. Goodbyes are hard, but we need to keep moving in life. As my commander Peggy Whitson fondly says, 'The only constant in spaceflight is change.' I believe that applies to life as well," he also wrote, "I guess at the end of the day - 'Yun hi chala chal rahi - jeevan gaadi hai samay pahiya'," recalling the song from the Bollywood movie Swades, which was on his playlist just before he embarked on the Axiom-4 mission to the ISS on June 25 from the and his backup astronaut Nair participated in the Independence Day celebrations at the Indian Consulate in Houston on Friday.
News18
4 hours ago
- News18
Smoking status must be captured in cancer trials, experts say in new study
New Delhi, Aug 17 (PTI) A group of experts from AIIMS Delhi, McMaster University in Canada and the International Agency for Research on Cancer (IARC) in France has stressed the need to record smoking status in cancer clinical trials, warning that continued tobacco use can reduce treatment efficacy and patient survival. In a commentary published in the Lancet Oncology this month, the seven authors, including Dr Abhishek Shankar from AIIMS Delhi, said knowledge of smoking status during therapy could influence clinical decisions. They argued that addressing barriers to tobacco-use assessment and embedding smoking cessation initiatives into oncology research protocols will improve trial outcomes, enhance therapeutic efficacy and save lives. The researchers cited the 2014 US Surgeon General's report 'The Health Consequences of Smoking — 50 Years of Progress', which for the first time concluded there was a causal link between cigarette smoking and adverse cancer-related outcomes, including higher all-cause and cancer-specific mortality. This report underscores the need to systematically capture smoking status in clinical trials, to refine estimates of efficacy of novel therapies and to better understand the impact of continued tobacco use across treatment modalities and disease sites. Since 2014, research has increasingly shown that continued tobacco use negatively impacts patients receiving surgery, radiotherapy or systemic therapies. The mechanisms by which tobacco smoke worsens outcomes remain unclear but may include tumour hypoxia, altered drug metabolism, stimulation of signalling pathways by nicotine and changes to the immune system, including reduced natural killer cells, the authors noted. 'Little is known about how best to overcome the effects of tobacco smoke, apart from cessation of tobacco use. Knowledge of smoking status during cancer therapy could potentially influence clinical decisions," the authors said in the commentary. They cited how the dose of erlotinib has to be doubled (from 150 mg to 300 mg daily) to achieve therapeutic concentrations in patients who continue smoking. 'These findings highlight a large gap in our understanding of how continued tobacco use might influence drug metabolism, therapeutic response and long-term outcomes," the experts said, adding that the issue is most pressing in low and middle-income countries with 80 per cent of tobacco users. Meta-analyses of lung, head and neck, hormone-responsive and other cancers show that quitting smoking after diagnosis results in longer survival, with early quitting offering the greatest benefits. The authors stressed that the survival advantage of quitting could even exceed the impact of the therapy under investigation. They also cautioned that failure to collect smoking data risks confounding trial results, especially if treatment groups are unbalanced for tobacco use. The commentary pointed out that the 2020 US Surgeon General's report recommended structured cessation efforts as standard cancer care, though it said more data was needed to confirm a causal link with improved survival. The authors referred to a 2020 US FDA–AACR–IASLC workshop which addressed the importance of tobacco-use assessment in oncology trials. Despite such efforts and published evidence, clinical trials still rarely incorporate robust tobacco-use assessments, they said. Absence of standardised tools and protocols for assessing tobacco use leads to inconsistencies in data collection, making it challenging to compare results across studies, authors added. They further said that some researchers and clinicians might perceive tobacco use as having minimal impact on clinical outcomes, leading to its omission from data collection. 'However, evidence strongly suggests that continued tobacco use can have a substantial adverse effect on cancer treatment efficacy and patient survival," the authors said. They also said that opportunities to intervene with current users after diagnosis have been missed, and more research is needed on mechanisms by which tobacco worsens outcomes. Collecting detailed smoking data requires time and resources, which might be limited in clinical trial settings, they pointed out. Electronic health record systems might not have integrated templates for recording smoking status information, leading to inconsistent documentation. The absence of automated prompts or referral systems can further impede the collection of accurate tobacco use data, the doctors said, adding that pharmaceutical manufacturers might perceive smoking status assessments as a threat. If smoking diminishes a drug's efficacy or exacerbates side-effects, it could negatively impact regulatory approval and market size, they added. Referring to a 2024 study by Cincirpini and colleagues, they said cessation support should ideally be provided within six months of diagnosis to observe the greatest survival benefit. With e-cigarette use rising globally, their use should also be captured in trials, though their impact is likely to be less severe than active smoking. In the past decade, many cancer centres in Canada, Australia and the US have made smoking cessation discussions standard practice at the time of patient registration, with advice and referrals offered. In 2023, the IASLC's Tobacco Control and Smoking Cessation Committee also issued a position statement declaring smoking status capture as a key standard for clinical trial design. 'Capturing smoking status in clinical trials should no longer be considered optional; it should be regarded as an essential core element of cancer research," the authors concluded. PTI PLB OZ OZ (This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments First Published: August 17, 2025, 18:00 IST News agency-feeds Smoking status must be captured in cancer trials, experts say in new study Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
